This may be due to the fact that the nature of acute inflammation in ACS is amplified by HSUA-induced oxidative stress and NLRP3 inflammasome activity, and these effects could cause inconsistent early outcomes like faster myocardial ischemia or stroke (4, 5). Here, NLRP3 is linked to stroke disorder.